• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

C1QBP 通过调节黄嘌呤氧化酶(XDH)介导的 ROS 生成来调控肾细胞癌细胞凋亡。

C1QBP regulates apoptosis of renal cell carcinoma via modulating xanthine dehydrogenase (XDH) mediated ROS generation.

机构信息

Department of Microbiology, School of Medical Laboratory, Tianjin Medical University, Tianjin 300203, China.

Department of Clinical Laboratory, Tianjin Children's Hospital/Tianjin University Children's Hospital, Tianjin 300134, China.

出版信息

Int J Med Sci. 2022 May 9;19(5):842-857. doi: 10.7150/ijms.71703. eCollection 2022.

DOI:10.7150/ijms.71703
PMID:35693733
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9149634/
Abstract

Complement component 1 Q subcomponent binding protein (C1QBP) plays a vital role in the progression and metabolism of cancer. Studies have shown that xanthine dehydrogenase (XDH)-derived reactive oxygen species (ROS) accelerates tumor growth, and also induces mutations or produces cytotoxic effects concurrently. However, the role of C1QBP in metabolism, oxidative stress, and apoptosis of renal cell carcinoma (RCC) cells have not yet been explored. Metabolomics assay was applied to investigate the role of C1QBP in RCC metabolism. C1QBP knockdown and overexpression cells were established via lentiviral infection and subjected to apoptosis and ROS assay . RNA stability assay was applied to characterize the mechanism of regulating transcription. , orthotopic tumor xenografts assay was performed to investigate the role of C1QBP in RCC progression. Metabolomics investigation revealed that C1QBP dramatically diminished the hypoxanthine content in RCC cells. C1QBP promoted the mRNA and protein expression of hypoxanthine catabolic enzyme XDH. Meanwhile, may affect transcription by regulating the mRNA level of transcriptional stimulators , , and . Moreover, the expression of C1QBP and XDH was lower in RCC tumors compared with the tumor-associated normal tissues, and their down-regulation was associated with higher Fuhrman grade. C1QBP significantly increased ROS level, apoptosis, and the expression of apoptotic proteins such as cleaved caspase-3 and bax/bcl2 via regulating XDH. C1QBP promotes the catabolism of hypoxanthine and elevates the apoptosis of RCC cells by modulating XDH-mediated ROS generation.

摘要

补体成分 1 Q 亚基结合蛋白(C1QBP)在癌症的进展和代谢中起着至关重要的作用。研究表明,黄嘌呤脱氢酶(XDH)衍生的活性氧(ROS)加速肿瘤生长,同时也诱导突变或产生细胞毒性作用。然而,C1QBP 在肾细胞癌(RCC)细胞代谢、氧化应激和细胞凋亡中的作用尚未被探索。代谢组学分析用于研究 C1QBP 在 RCC 代谢中的作用。通过慢病毒感染建立 C1QBP 敲低和过表达细胞,并进行细胞凋亡和 ROS 测定。应用 RNA 稳定性测定来表征调节转录的机制。进行原位肿瘤异种移植实验以研究 C1QBP 在 RCC 进展中的作用。代谢组学研究表明,C1QBP 显著降低了 RCC 细胞中的次黄嘌呤含量。C1QBP 促进了次黄嘌呤代谢酶 XDH 的 mRNA 和蛋白表达。同时,通过调节转录激活剂的 mRNA 水平,可能影响转录。此外,与肿瘤相关的正常组织相比,RCC 肿瘤中的 C1QBP 和 XDH 表达水平较低,其下调与更高的 Fuhrman 分级相关。C1QBP 通过调节 XDH 介导的 ROS 生成,显著增加了 ROS 水平、细胞凋亡以及 cleaved caspase-3 和 bax/bcl2 等凋亡蛋白的表达。C1QBP 通过调节 XDH 介导的 ROS 生成,促进次黄嘌呤的分解代谢,并增加 RCC 细胞的凋亡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f6/9149634/3e66500d8196/ijmsv19p0842g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f6/9149634/64dfcbec1c32/ijmsv19p0842g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f6/9149634/62267d3e77b2/ijmsv19p0842g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f6/9149634/2a64d520ab63/ijmsv19p0842g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f6/9149634/72489c18dc1d/ijmsv19p0842g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f6/9149634/02f7a012823a/ijmsv19p0842g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f6/9149634/3e66500d8196/ijmsv19p0842g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f6/9149634/64dfcbec1c32/ijmsv19p0842g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f6/9149634/62267d3e77b2/ijmsv19p0842g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f6/9149634/2a64d520ab63/ijmsv19p0842g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f6/9149634/72489c18dc1d/ijmsv19p0842g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f6/9149634/02f7a012823a/ijmsv19p0842g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f6/9149634/3e66500d8196/ijmsv19p0842g007.jpg

相似文献

1
C1QBP regulates apoptosis of renal cell carcinoma via modulating xanthine dehydrogenase (XDH) mediated ROS generation.C1QBP 通过调节黄嘌呤氧化酶(XDH)介导的 ROS 生成来调控肾细胞癌细胞凋亡。
Int J Med Sci. 2022 May 9;19(5):842-857. doi: 10.7150/ijms.71703. eCollection 2022.
2
C1QBP negatively regulates the activation of oncoprotein YBX1 in the renal cell carcinoma as revealed by interactomics analysis.相互作用组学分析显示,C1QBP在肾细胞癌中负向调节癌蛋白YBX1的激活。
J Proteome Res. 2015 Feb 6;14(2):804-13. doi: 10.1021/pr500847p. Epub 2014 Dec 26.
3
C1QBP Regulates YBX1 to Suppress the Androgen Receptor (AR)-Enhanced RCC Cell Invasion.C1QBP通过调控YBX1抑制雄激素受体(AR)增强的肾癌细胞侵袭。
Neoplasia. 2017 Feb;19(2):135-144. doi: 10.1016/j.neo.2016.12.003. Epub 2017 Jan 17.
4
Hepatocyte growth factor suppresses hypoxia/reoxygenation-induced XO activation in cardiac microvascular endothelial cells.肝细胞生长因子抑制心脏微血管内皮细胞中缺氧/复氧诱导的黄嘌呤氧化酶激活。
Heart Vessels. 2015 Jul;30(4):534-44. doi: 10.1007/s00380-014-0547-y. Epub 2014 Jul 26.
5
High molecular weight fibroblast growth factor 2 induces apoptosis by interacting with complement component 1 Q subcomponent-binding protein in vitro.高分子量成纤维细胞生长因子 2 通过与补体成分 1 Q 亚基结合蛋白相互作用在体外诱导细胞凋亡。
J Cell Biochem. 2018 Nov;119(11):8807-8817. doi: 10.1002/jcb.27131. Epub 2018 Aug 29.
6
Xanthine oxidase-mediated oxidative stress promotes cancer cell-specific apoptosis.黄嘌呤氧化酶介导的氧化应激促进癌细胞特异性凋亡。
Free Radic Biol Med. 2019 Aug 1;139:70-79. doi: 10.1016/j.freeradbiomed.2019.05.019. Epub 2019 May 16.
7
C1QBP suppresses cell adhesion and metastasis of renal carcinoma cells.C1QBP 抑制肾癌细胞的黏附和转移。
Sci Rep. 2017 Apr 20;7(1):999. doi: 10.1038/s41598-017-01084-w.
8
Modulation of renal xanthine oxidoreductase in aging: gene expression and reactive oxygen species generation.衰老过程中肾脏黄嘌呤氧化还原酶的调节:基因表达与活性氧生成
J Nutr Health Aging. 1999;3(1):19-23.
9
Xanthine dehydrogenase and xanthine oxidase activity and gene expression in renal epithelial cells. Cytokine and steroid regulation.肾上皮细胞中的黄嘌呤脱氢酶和黄嘌呤氧化酶活性及基因表达。细胞因子和类固醇调节。
J Immunol. 1994 Aug 15;153(4):1789-97.
10
Transfection of poly(I:C) can induce reactive oxygen species-triggered apoptosis and interferon-β-mediated growth arrest in human renal cell carcinoma cells via innate adjuvant receptors and the 2-5A system.聚肌苷酸-聚胞苷酸(poly(I:C))转染可通过天然佐剂受体和2-5A系统在人肾癌细胞中诱导活性氧触发的细胞凋亡和干扰素-β介导的生长停滞。
Mol Cancer. 2014 Sep 17;13:217. doi: 10.1186/1476-4598-13-217.

引用本文的文献

1
CRISPR/Cas9 mediated ENT2 gene knockout altered purine catabolic pathway and induced apoptosis in colorectal cell lines.CRISPR/Cas9介导的ENT2基因敲除改变了嘌呤分解代谢途径并诱导大肠癌细胞系凋亡。
PLoS One. 2025 Aug 18;20(8):e0329501. doi: 10.1371/journal.pone.0329501. eCollection 2025.
2
C1QBP promotes apoptosis of goat fetal turbinate cells via inhibiting the expression of TRIM5 or TNFSF10.C1QBP通过抑制TRIM5或TNFSF10的表达促进山羊胎儿鼻甲细胞凋亡。
Front Vet Sci. 2025 May 16;12:1524734. doi: 10.3389/fvets.2025.1524734. eCollection 2025.
3
Quantitative Proteomics Analysis Reveals XDH Related with Ovarian Oxidative Stress Involved in Broodiness of Geese.

本文引用的文献

1
Bcl-xL: A Focus on Melanoma Pathobiology.Bcl-xL:聚焦黑色素瘤病理生物学。
Int J Mol Sci. 2021 Mar 9;22(5):2777. doi: 10.3390/ijms22052777.
2
Development of Mcl-1 inhibitors for cancer therapy.开发用于癌症治疗的 Mcl-1 抑制剂。
Eur J Med Chem. 2021 Jan 15;210:113038. doi: 10.1016/j.ejmech.2020.113038. Epub 2020 Nov 24.
3
The role of IL-1β and TNF-α in intervertebral disc degeneration.白细胞介素-1β和肿瘤坏死因子-α在椎间盘退变中的作用。
定量蛋白质组学分析揭示与参与鹅抱窝行为的卵巢氧化应激相关的黄嘌呤脱氢酶
Animals (Basel). 2025 Jan 11;15(2):182. doi: 10.3390/ani15020182.
4
p32 regulates glycometabolism and TCA cycle to inhibit ccRCC progression via copper-induced DLAT lipoylation oligomerization.p32 通过铜诱导的 DLAT 脂酰化寡聚化来调节糖代谢和 TCA 循环,从而抑制 ccRCC 的进展。
Int J Biol Sci. 2024 Jan 1;20(2):516-536. doi: 10.7150/ijbs.84399. eCollection 2024.
5
Genome-wide association study of abnormal elevation of ALT in patients exposed to atabecestat.在接触阿他贝斯特的患者中丙氨酸氨基转移酶升高的全基因组关联研究。
BMC Genomics. 2023 Sep 1;24(1):513. doi: 10.1186/s12864-023-09625-6.
6
Increased expression and its association with altered purine metabolism in cell lines derived from different stages of colorectal cancer.在源自不同阶段结直肠癌的细胞系中表达增加及其与嘌呤代谢改变的关联。
Exp Ther Med. 2023 Mar 24;25(5):212. doi: 10.3892/etm.2023.11911. eCollection 2023 May.
Biomed Pharmacother. 2020 Nov;131:110660. doi: 10.1016/j.biopha.2020.110660. Epub 2020 Aug 24.
4
Berberine associated photodynamic therapy promotes autophagy and apoptosis via ROS generation in renal carcinoma cells.小檗碱相关的光动力疗法通过 ROS 的产生促进肾癌细胞自噬和凋亡。
Biomed Pharmacother. 2020 Mar;123:109794. doi: 10.1016/j.biopha.2019.109794. Epub 2019 Dec 23.
5
Combination with Stereotactic Body Radiotherapy Offers a Promising Strategy to Overcome Resistance to Immunotherapy in Advanced Renal Cell Cancer.立体定向体部放疗联合提供了一种有前景的策略来克服晚期肾细胞癌对免疫治疗的耐药性。
J Oncol. 2019 Nov 28;2019:1483406. doi: 10.1155/2019/1483406. eCollection 2019.
6
The C1q Receptors: Focus on gC1qR/p33 (C1qBP, p32, HABP-1).C1q 受体:关注 gC1qR/p33(C1qBP、p32、HABP-1)。
Semin Immunol. 2019 Oct;45:101338. doi: 10.1016/j.smim.2019.101338. Epub 2019 Nov 16.
7
Investigational MET inhibitors to treat Renal cell carcinoma.用于治疗肾细胞癌的研究性 MET 抑制剂。
Expert Opin Investig Drugs. 2019 Oct;28(10):851-860. doi: 10.1080/13543784.2019.1673366. Epub 2019 Oct 3.
8
USP19 Inhibits TNF-α- and IL-1β-Triggered NF-κB Activation by Deubiquitinating TAK1.USP19 通过去泛素化 TAK1 抑制 TNF-α 和 IL-1β 触发的 NF-κB 激活。
J Immunol. 2019 Jul 1;203(1):259-268. doi: 10.4049/jimmunol.1900083. Epub 2019 May 24.
9
Genomic signatures defining responsiveness to allopurinol and combination therapy for lung cancer identified by systems therapeutics analyses.通过系统治疗学分析鉴定出基因组特征,可定义对肺癌的别嘌醇和联合治疗的反应性。
Mol Oncol. 2019 Aug;13(8):1725-1743. doi: 10.1002/1878-0261.12521. Epub 2019 Jul 10.
10
Xanthine oxidase-mediated oxidative stress promotes cancer cell-specific apoptosis.黄嘌呤氧化酶介导的氧化应激促进癌细胞特异性凋亡。
Free Radic Biol Med. 2019 Aug 1;139:70-79. doi: 10.1016/j.freeradbiomed.2019.05.019. Epub 2019 May 16.